Sotera Health Company
NASDAQSotera Health arrives at mid-week with an unusual combination: short interest up nearly 47% over the past month while Goldman Sachs has just stepped in with a fresh Buy rating and Barclays lifted its target on Tuesday. The analyst picture is the clearest bullish signal in this setup. Goldman initiated coverage on June 5 with a Buy and a $20 target — the first bellwether firm to…
SHC put-call ratio hits 4.1 standard deviations above mean at 0.0713, signaling extreme call dominance; ratio 21% above 20-day average of 0.0588.
Snapshot as of 6 Aug 2026
Sotera Health arrives at mid-week with an unusual combination: short interest up nearly 47% over the past month while Goldman Sachs has just stepped in with a fresh Buy rating and Barclays lifted its target on…
Sotera Health Company posted a Q1 earnings beat this week, reaffirmed its 2026 revenue outlook, and unveiled a CEO transition — yet short interest has climbed more than 50% over the past month, raising an obvious…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SHC — free to start on ORTEX.
Sign up for free →Open SHC on ORTEX